Thailand Viral Respiratory Infections Treatment Market to 2032
Overview
The Thailand Viral Respiratory Infections Treatment Market is expected to reach a 1,100.59 USD Million by 2032 and is projected to grow at a CAGR of 8.12% from 2025 to 2032.
Revenue, 2024 (USD Million)
669.55
Forecast, 2032 (USD Million)
1,100.59
CAGR, 2024 - 2032
8.12%
Report Coverage
Thailand
Thailand Viral Respiratory Infections Treatment Market 2018-2032 USD Million
Thailand Viral Respiratory Infections Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 669.55 USD Million
- Projected Market Size (2032): 1,100.59 USD Million
- CAGR (2025-2032): 8.12%
Key Findings of Thailand Viral Respiratory Infections Treatment Market
- The Thailand Viral Respiratory Infections Treatment Market was valued at 669.55 USD Million in 2024.
- The Thailand Viral Respiratory Infections Treatment Market is likely to grow at a CAGR of 8.12% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription Based in Type Segment accounted for the largest share of the market with a revenue of 512.44 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 8.89% during the forecast period from 2024 to 2032.
Thailand Viral Respiratory Infections Treatment Market Scope
Thailand Viral Respiratory Infections Treatment Market Segmentation & Scope
Treatment Type
- Vaccine
- Others
- Monoclonal Antibdodies
- Antiviral Medications
- Non-Steroidal Anti-Inflammatory (NSAIDs)
Type
- OTC
- Prescription Based
Route of Administration
- Nasal
- Injectable
- Oral
Infection Type
- Lower Respiratory Infections
- Upper Respiratory Infections
Disease Type
- Others
- Parainfluenza
- Influenza (FLU)
- Respiratory Syncytial Virus (RSV)
- Enterovirus
- Adenoviruses
- Rhinovirus (Common Cold)
- Covid
Population
- Geriatric
- Adults
- Pediatric
Distribution Channel
- Retail Sales
- Direct Tender
- Others
End User
- Research Institutes and Academic Centers
- Home Care Settings
- Clinics
- Ambulatory Surgical Centers
- Hospitals
Gender
- Female
- Male
Thailand Viral Respiratory Infections Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 669.55 USD Million |
| Market Value in 2032 | 1,100.59 USD Million |
| CAGR (2025-2032) | 8.12% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment Type,Type,Route of Administration,Infection Type,Disease Type,Population,Distribution Channel,End User,Gender |
Regional Insights:
-
Leading Market (2024-2032): Thailand, leading in terms of revenue 669.55 USD Million in 2024
- Key Country: Thailand, leading in terms of revenue with value of 669.55 USD Million in 2024.
Segments and Scope
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Treatment Type
- Non-Steroidal Anti-Inflammatory (NSAIDs) is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 276.57 USD Million in the year 2024.
- Non-Steroidal Anti-Inflammatory (NSAIDs) is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.75 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Type
- Prescription Based is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 512.44 USD Million in the year 2024.
- Prescription Based is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.26 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Route of Administration
- Nasal is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 409.32 USD Million in the year 2024.
- Nasal is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.39 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Infection Type
- Lower Respiratory Infections is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 404.12 USD Million in the year 2024.
- Lower Respiratory Infections is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.49 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Disease Type
- Rhinovirus (Common Cold) is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 144.98 USD Million in the year 2024.
- Rhinovirus (Common Cold) is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 7.93 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Population
- Geriatric is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 307.36 USD Million in the year 2024.
- Geriatric is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.71 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 329.97 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.53 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By End User
- Hospitals is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 263.78 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.89 % in forecast period 2025-2032.
-
Thailand Viral Respiratory Infections Treatment Market to 2032, By Gender
- Male is the largest segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a revenue of 420.73 USD Million in the year 2024.
- Male is the Fastest growing segment in Thailand Viral Respiratory Infections Treatment Market to 2032 with a Growth rate of 8.41 % in forecast period 2025-2032.
Thailand Viral Respiratory Infections Treatment Market Company Share Analysis
| Company Name |
|
||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Gilead Sciences, Inc. | |||
| GSK plc. | |||
| F. Hoffmann-La Roche Ltd. | |||
Thailand Viral Respiratory Infections Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Thailand Viral Respiratory Infections Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Thailand Viral Respiratory Infections Treatment Market is segmented based on Segmentation Treatment Type,Type,Route of Administration,Infection Type,Disease Type,Population,Distribution Channel,End User,Gender.
Thailand Viral Respiratory Infections Treatment Market was valued at USD 669.55(Revenue in USD Million) in 2022.
Thailand Viral Respiratory Infections Treatment Market is projected to grow at a CAGR of 8.12% during the forecast period of 2024 to 2032.
The Prescription Based segment is expected to dominate the Thailand Viral Respiratory Infections Treatment Market, holding a largest market share of 512.44 USD Million in 2024
Thailand Viral Respiratory Infections Treatment Market Scope
Thailand Viral Respiratory Infections Treatment Market Segmentation & Scope
Treatment Type
- Vaccine
- Others
- Monoclonal Antibdodies
- Antiviral Medications
- Non-Steroidal Anti-Inflammatory (NSAIDs)
Type
- OTC
- Prescription Based
Route of Administration
- Nasal
- Injectable
- Oral
Infection Type
- Lower Respiratory Infections
- Upper Respiratory Infections
Disease Type
- Others
- Parainfluenza
- Influenza (FLU)
- Respiratory Syncytial Virus (RSV)
- Enterovirus
- Adenoviruses
- Rhinovirus (Common Cold)
- Covid
Population
- Geriatric
- Adults
- Pediatric
Distribution Channel
- Retail Sales
- Direct Tender
- Others
End User
- Research Institutes and Academic Centers
- Home Care Settings
- Clinics
- Ambulatory Surgical Centers
- Hospitals
Gender
- Female
- Male
Frequently Asked Questions
The Thailand Viral Respiratory Infections Treatment Market is segmented based on Segmentation Treatment Type,Type,Route of Administration,Infection Type,Disease Type,Population,Distribution Channel,End User,Gender.
Thailand Viral Respiratory Infections Treatment Market was valued at USD 669.55(Revenue in USD Million) in 2022.
Thailand Viral Respiratory Infections Treatment Market is projected to grow at a CAGR of 8.12% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Viral Respiratory Infections Treatment Market for final year is USD 1,100.59 (USD Million).
Thailand Viral Respiratory Infections Treatment Market Company Profiling
Frequently Asked Questions
The Thailand Viral Respiratory Infections Treatment Market is segmented based on Segmentation Treatment Type,Type,Route of Administration,Infection Type,Disease Type,Population,Distribution Channel,End User,Gender.
Thailand Viral Respiratory Infections Treatment Market was valued at USD 669.55(Revenue in USD Million) in 2022.
Thailand Viral Respiratory Infections Treatment Market is projected to grow at a CAGR of 8.12% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Viral Respiratory Infections Treatment Market for final year is USD 1,100.59 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.